Nirsevimab (Beyfortus), an antibody targeting respiratory syncytial virus (RSV), is indicated for newborns and infants to prevent bronchiolitis. Available since September 2023, its widespread use may ...

Typhoid fever, an illness that has been controlled in developed countries since the early 20th century, is evolving to be antibiotic-resistant. Research published in 2022 shows that typhoid is ...

Scientists have discovered a way to control mutation rates in bacteria, paving the way for new strategies to combat antibiotic resistance. Antibiotics are given to kill bad bacteria; however, with ...

The bacteria Acinetobacter baumannii (A. baumannii) is a haunting presence in many hospitals in the United States, where more than one in 100 patients are treated for A. baumannii infections. This ...

Tamiflu, the same antiviral used to treat ordinary seasonal influenza, is the front line medication recommended for treating highly pathogenic bird flu (Photo by Rui Vieira/PA Images via Getty Images) ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in ...

Investigators at Mass General Brigham have uncovered how resistance to chemotherapies may occur in some cancers. Researchers focused on a pathway that harnesses reactive oxygen species (ROS) to kill ...

In addition to the new data that illustrate how L74V may affect zidovudine susceptibility, an array of new studies on the interplay of L74V with other NRTI-associated resistance mutations were ...